Clinical Trials on HER2-Positive Solid Tumor

Total 5914 results

jianming xu
NeoCura

Recruiting

A Safety and Efficacy Study of XH001 Combined With Sintilimab Injection in Advanced Solid Tumors

Solid Tumor

China
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Clinical Study of IBI130 for Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

Solid Tumor

Australia
Betta Pharmaceuticals Co., Ltd.

Recruiting

BPB-101 in Subjects With Metastatic or Locally Advanced Solid Tumors

Solid Tumor

China
Jemincare

Not yet recruiting

JYB1907 in Subjects With Advanced Solid Tumors

Solid Tumor
Eutilex

Recruiting

A Phase 1 Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of EU103 in Advanced or Metastatic Solid Tumors That Have Failed Standard Therapy

Solid Tumor

Korea, Republic of
920th Hospital of Joint Logistics Support Force...

Recruiting

A Study of RD14-01 in Patients With Advanced Solid Tumors

Solid Tumor

China
Ganzhou Hemay Pharmaceutical Co., Ltd

Recruiting

A Phase I Study of Hemay181 in Patients With Advanced Solid Tumors

Solid Tumor

China
Chugai Pharmaceutical

Recruiting

A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

Solid Tumor

United States, Japan
Grit Biotechnology

Recruiting

Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Solid Tumors

Solid Tumor

China
Pyxis Oncology, Inc

Recruiting

Study of PYX-106 in Solid Tumors

Solid Tumor

United States, Spain, Belgium
Selecxine

Recruiting

A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination

Advanced Solid Tumor

United States, Australia, Korea, Republic of
Toray Industries, Inc

Recruiting

A Study of TRK-950 in Patients With Advanced Solid Tumors

Solid Tumor

Japan
Odense University Hospital

Recruiting

PREcision Medicine in Cancer in Odense, Denmark (PRECODE)

Metastatic Solid Tumor

Denmark
Shanghai Mengchao Cancer Hospital
Shanghai Cell Therapy Group Co.,Ltd

Recruiting

αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors

Solid Tumor

China
YueJuan Cheng
NeoCura

Recruiting

Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Solid Tumors

Solid Tumor

China
Betta Pharmaceuticals Co., Ltd.

Recruiting

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BPI-21668

Advanced Solid Tumor

China
Peking University Cancer Hospital & Institute

Not yet recruiting

Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors

Solid Tumor
Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Recruiting

Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of ASKC202

Advanced Solid Tumor

China
Royal Marsden NHS Foundation Trust

Recruiting

Improving Cyberknife Spinal Stereotactic Radiotherapy in Difficult to Treat Cases (IMPRESS) (IMPRESS)

Solid Tumor, Adult

United Kingdom
Shandong Cancer Hospital and Institute

Not yet recruiting

A Phase I Study of IBI325 in Patients With Advanced Solid Tumor

Solid Tumor

China
Children's National Research Institute

Recruiting

Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors

Solid Tumor

United States
Bliss Biopharmaceutical (Hangzhou) Co., Ltd

Recruiting

A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors

Solid Tumor

China
Stemirna Therapeutics

Recruiting

A Study of Neoantigen mRNA Personalised Cancer in Patients With Advanced Solid Tumors

Solid Tumor

Australia, Austria
The First Affiliated Hospital with Nanjing Medical...
Shanghai IASO Biotechnology Co., Ltd

Recruiting

An Exploratory Clinical Study of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors

Solid Tumor

China
iTeos Therapeutics

Recruiting

New Formulation Study of Inupadenant (EOS100850) in Patients With Cancer

Solid Tumor, Adult

Belgium, United Kingdom
Nanjing Leads Biolabs Co.,Ltd

Recruiting

Phase I/II Clinical Trial of LBL-015 for Injection

Advanced Solid Tumor

China
Chang Gung Memorial Hospital

Recruiting

Neoantigen-expanded Autologous Immune Cell Therapy

Advanced Solid Tumor

Taiwan
Shanghai Henlius Biotech

Recruiting

HLX208 (BRAF V600E Inhibitor) in Combination With Trametinib in Patients With Advanced Solid Tumors

Solid Tumor

China
Beijing Biostar Pharmaceuticals Co., Ltd.
Chengdu Biostar Pharmaceuticals

Recruiting

Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors

Solid Tumor

China
University College, London
Imperial College London; Cancer Research UK; National Cancer Imaging Translational...

Recruiting

[18F]FPIA PET/CT Imaging in Patients With Solid Tumours ([18F]FPIA)

Cancer | Tumor, Solid

United Kingdom
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors

Solid Tumor

China
Sunnybrook Health Sciences Centre
University of Toronto; Princess Margaret Hospital, Canada

Recruiting

Tumor Immunotherapy and Microbiome Analysis (TIME)

Advanced Solid Tumor

Canada
Intra-IMMUSG Pte Ltd
Parexel

Recruiting

A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors

Solid Tumor

United States
Yantai Yuhuangding Hospital

Recruiting

Study of NK Combined With Chemotherapy for Advanced Solid Tumor (NK)

Solid Tumor

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Recruiting

Study of Dosage Exploration and Pharmacokinetics for HA121-28 Tablets

Advanced Solid Tumor

China
University Hospital of Ferrara

Recruiting

Analysis of Chemical Pattern Exhaled by Different Neoplasms Through Chemoresistive Nanostructured Sensors

Tumor, Solid

Italy
Guangzhou FineImmune Biotechnology Co., LTD.
Sun Yat-sen University

Recruiting

Individualized Tumor Specific TCR- T Cells in the Treatment of Advanced Solid Tumors

Solid Tumor

China
Shanghai Kechow Pharma, Inc.

Recruiting

A PhaseI Study of HL-085 Plus Vemurafenib in Solid Tumor With BRAF V600 Mutation

Solid Tumor

China
Institut National de la Santé Et de la Recherche...
National Research Agency, France; Ligue contre le cancer, France; Programme hospitalier...

Recruiting

French Childhood Cancer Survivor Study (FCCSS)

Childhood Solid Tumor

France
Genmab
BioNTech SE

Active, not recruiting

GEN1046 Safety and PK in Subjects With Advanced Solid Malignancies

Solid Tumor

Japan
Zhao Siyao

Active, not recruiting

A Machine Learning-based Estimated Survival Model

Advanced Solid Tumor

China
Tomsk National Research Medical Center of the Russian...
Uppsala University

Enrolling by invitation

Molecular Imaging of EpCAM Receptors Using [99mTc]Tc(CO)3-(HE)3-Ec1

Solid Tumor, Adult

Russian Federation
Shanghai Pharmaceuticals Holding Co., Ltd

Completed

A Food Effect Study of SPH5030 Tablets.

Advanced Solid Tumor

China
BioNTech SE

Active, not recruiting

BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors

Solid Tumor

United States, Spain
Shenzhen NewDEL Biotech, Co., Ltd
Shenzhen Innovation Center for Small Molecule Drug Discovery Co., Ltd.

Enrolling by invitation

An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers

Advanced Solid Tumor

China
Sirnaomics

Active, not recruiting

Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors

Solid Tumor

United States
InteRNA

Terminated

First-in-Human Study of INT-1B3 in Patients With Advanced Solid Tumors

Solid Tumor

Netherlands, Belgium
Dana-Farber Cancer Institute

Active, not recruiting

The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study

Pediatric Solid Tumor

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Astex Pharmaceuticals, Inc.

Active, not recruiting

Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors

Solid Tumor

United States
BeiGene

Active, not recruiting

Safety, Pharmacokinetics, and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab (BGB-A317) in Participants With Advanced Solid Tumors

Solid Tumor

Australia, United States

Clinical Trials on HER2-Positive Solid Tumor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations